The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease
Berkeley Pharma Tech Journal of Medicine · 2021
DOI: 10.52243/bptjm.v1i1.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Berkeley Pharma Tech Journal of Medicine, 2021. Verfasst von Nidhi Kanchumarthi und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is one of the most prevalent and debilitating neurodegenerative diseases in the world, highlighting the need for research on novel treatments and therapies. Previous studies have found that the body’s endocannabinoid system (ECS) interacts closely with its neural system, making it a potential avenue for the treatment of neurological disorders. One hallmark of AD is the accumulation of amyloid-beta (Aβ) in the brain and its potentially detrimental effects on cognitive function. Cannabis-based drugs have been observed to regulate Aβ modifications and inhibit AD progression. Furthermore, cannabinoids have been noted to reduce inflammation and neurotoxicity. Synthetic cannabinoids were able to rescue memory deficits and neurodegeneration, and reduce immunoreactivity. Similarly, natural cannabinoids like Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) demonstrate therapeutic potential by interacting with the cholinergic system, and reversing the symptoms of AD. Although further research and testing are needed, it is evident that the use of cannabinoids shows promise for future treatment in AD patients.
Zitieren
APA
Kanchumarthi, N., Rockland, A., Vembar, T., Liu, E., Kanaad, R., Hinojosa, E. T., Tiv, K., Chen, B., Hao, S., Guttikonda, S., & Garza, R. (2021). The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease. Berkeley Pharma Tech Journal of Medicine. https://doi.org/10.52243/bptjm.v1i1.12
Vancouver
Kanchumarthi N, Rockland A, Vembar T, Liu E, Kanaad R, Hinojosa ET, et al. The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease. Berkeley Pharma Tech Journal of Medicine. 2021. doi:10.52243/bptjm.v1i1.12
BibTeX
@article{Kanchumarthi2021,
author = {Kanchumarthi, Nidhi and Rockland, Avigail and Vembar, Thejaswini and Liu, Elaine and Kanaad, Rithvik and Hinojosa, Erick Torres and Tiv, Kira and Chen, Benjamin and Hao, Shira and Guttikonda, Sri and Garza, Ramiro},
title = {The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease},
journal = {Berkeley Pharma Tech Journal of Medicine},
year = {2021},
doi = {10.52243/bptjm.v1i1.12}
}
EUVIMED